Collectively, our results uncover a novel mechanism in which Smad4‐independent TGF‐β signaling mediates colitis and CAC development via YAP and may provide therapeutic insights into the treatment of these gastrointestinal diseases. This evidence concerns the gene TGFB1 and colitis.